Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by L. D. Volk-Draper
TLR4 Is a Novel Determinant of the Response to Paclitaxel in Breast Cancer
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
Trop-2 Is a Determinant of Breast Cancer Survival
PLoS ONE
Multidisciplinary
Paclitaxel in Breast Cancer
Oncologist
Cancer Research
Medicine
Oncology
Enriched Variations in TEKT4 and Breast Cancer Resistance to Paclitaxel
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
The 4e-Bp1/eIF4E Ratio Is a Determinant for Rapamycin Response in Esophageal Cancer Cells
Journal of Thoracic and Cardiovascular Surgery
Respiratory Medicine
Pulmonary
Cardiovascular Medicine
Surgery
Cardiology
Dramatic Response to Carboplatin, Paclitaxel, and Radiation in a Patient With Malignant Myoepithelioma of the Breast
Oncologist
Cancer Research
Medicine
Oncology
Aurora Kinase a Stabilizes FOXM1 to Enhance Paclitaxel Resistance in Triple‐negative Breast Cancer
Journal of Cellular and Molecular Medicine
Molecular Medicine
Cell Biology
Anti-Her2 CD4+ T-Helper Type 1 Response Is a Novel Immune Correlate to Pathologic Response Following Neoadjuvant Therapy in HER2-positive Breast Cancer
Breast Cancer Research
Cancer Research
Oncology
Oral Paclitaxel in the Treatment of Metastatic Breast Cancer (MBC) Patients.
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Paclitaxel-Induced Apoptosis Is Blocked by Camptothecin in Human Breast and Pancreatic Cancer Cells
Oncology Reports
Medicine
Cancer Research
Oncology